Idebenone induces oxygen consumption rate modifications in aged rat brain mitochondria

Archives of Gerontology and Geriatrics

Volumn 24, Issue 1, 1997, Pages 55-66

  Bet, Luciano ^a   Orsina, Natale ^b   Celeste, Salvatore ^b   Rapuzzi, Sara ^a   Pifferi, Silvia ^a   Scarlato, Guglielmo ^a   Mariani, Claudio ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Zona Industriale   (Italy)

Author keywords

Ageing; Brain mitochondria; Idebenone; Lipid peroxidation

Indexed keywords

ADENOSINE DIPHOSPHATE; IDEBENONE; MALIC ACID; NOOTROPIC AGENT; PYRUVIC ACID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

AGE; AGING; ANIMAL EXPERIMENT; ARTICLE; BRAIN MITOCHONDRION; CONTROLLED STUDY; ENZYME ACTIVITY; LIPID PEROXIDATION; MALE; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXYGEN CONSUMPTION; POLAROGRAPHY; PRIORITY JOURNAL; RAT;

EID: 0031036498     PISSN: 01674943     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4943(96)00742-X     Document Type: Article

References (29)

1. Adelman, R., Saul, R.L. and Ames, B.N. (1988): Oxidative damage to DNA: reaction to species metabolic rate and life span. Proc. Natl. Acad. Sci. USA, 85, 2706-2708.
2. Bandy, B. and Davison, A.J. (1990): Mitochondria mutations may increase oxidative stress implications for carcinogenics and aging? Free Radie. Biol. Med., 8, 523-539.
3. Bresolin, N., Zeviani, M., Bonilla, E., Miller, R.H., Leech, R.W., Shanske, S., Nakagawa, M. and Di Mauro, S. (1985): Fatal infantile cytochrome c oxidase deficiency: decrease of immunologically detectable enzyme in muscle. Neurology, 35, 802-812.
4. Clark, J.B. and Nicklas, W.J. (1970): The metabolism of rat brain mitochondria. J. Biol. Chem., 254, 4724-4731.
5. Cooper, J.M., Mann, V.M. and Schapira, A.H. (1992): Analyses of mitochondrial respiratory chain function and mitochondrial DNA deletion in human skeletal muscle: effect of ageing. J. Neurol. Sci., 113, 91-98.
6. Corral-Debrinski, M., Horton, T., Lott, M.T., Shoffner, J.M., Beal, M.F. and Wallace, D.C. (1992): Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age. Nat. Genet., 2, 324-329.
7. Cortopassi, G.A. and Arnheim, N. (1990): Detection of a specific mitochondrial DNA deletion in tissues of older humans. Nucleic Acids Res., 18, 6927-6933.
8. De Lustig, E.S., Serra, J.A., Kohan, S., Canziani, G.A., Famulari, A.L. and Dominguez, R.O. (1993): Copper-zinc Superoxide dismutase activity in red blood cells and serum in demented patients and in aging. J. Neurol. Sci., 115, 18-25.
9. Donà, G., Bontà, L., Sacchelli, C., Casale, G. and De Nicola, P. (1988): A double-bind study of the efficacy of idebenone in the treatment of patients with cognitive deficit due to cerebrovascular disease. Acta Gerontol., 38, 188-192.
10. Ihara, Y., Namba, R., Kuroda, S., Sato, T. and Shirabe, T. (1989): Mitochondrial encephalomyopathy (MELAS): pathological study and successful therapy with coenzyme Q10 and idebenone. J. Neurol. Sci., 90, 263-271.
11. Imada, I., Fujita, T., Sugiyama, Y., Okamoto, K. and Kobayashi, Y. (1989): Effects of idebenone and related compounds on the respiratory activities of brain mitochondria, and on lipid peroxidation of their membranes. Arch. Gerontol. Geriatr., 8, 323-342.
12. Lowry, O.H., Rosenbrough, N.J., Farr, A.L. and Randall, R.J. (1951): Protein measurements with Folin phenol reagent. J. Biol. Chem., 193, 265-275.
13. Mashima, Y., Hiida, Y. and Oguchi, Y. (1992): Remission of Leber's hereditary optic neuropathy with idebenone. Lancet, 340, 368-369.
14. Nagaoka, A., Suno, M. and Kakihana, M. (1989): Effects of idebenone on neurological deficits, local cerebral flow and energy metabolism in rats with experimental cerebral ischemia. Arch. Gerontol. Geriatr., 8, 193-202.
15. Nagy, K. and Zs-Nagy, I. (1990): The effect of idebenone on the Superoxide dismutase, catalase and glutathione peroxidase activities in liver and brain homogenates, as well as in brain synaptosomal and mitochondrial fractions. Arch. Gerontol. Geriatr., 11, 285-292.
16. Parker, W.D., Filley, C.M. and Parks, J.K. (1990a): Cytochrome c oxidase deficiency in Alzheimer's disease. Neurology, 40, 1302-1303.
17. Parker, W.D., Boyson, S.J., Luder, A.S. and Parks, J.K. (1990b): Evidence for a defect in NADH: ubiquinone oxidoredoctase (complex I) in Huntington's disease. Neurology, 40, 1231-1234.
18. Pikò, L., Hougham, A.J. and Bulpitt, K.J. (1988): Studies of sequence heterogeneity of mitochondrial DNA from rat and mouse tissue: evidence for an increased frequency of deletions/additions with aging. Mech. Age Dev., 43, 279-293.
19. Rosen, D.R., Siddique, T., Patterson, D., Figlewicz, D.A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J.P., Deng, H.X., Rahmani, Z., Krizus, A., McKenna-Yasek, D., Cayabyab, A., Gaston, S.M., Berger, R., Tanzi, R.E., Halperin, J.J., Herzfeldt, B., Van den Bergh, R., Hung, W.Y., Bird, T., Deng, G., Mulder, D.W., Smyth, C., Laing, N.G., Soriano, E., Pericak-Vance, M.A., Haines, J., Rouleau, G.A., Gusella, J.S., Horvitz, H.R. and Brown Jr, R.H. (1993): Mutations in Cu/Zn Superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature, 362, 59-62.
20. Schapira, A.H., Holt, I.J., Sweeney, M., Harding, A.E., Jenner, P. and Marsden, C.D. (1990): Mitochondrial DNA analysis in Parkinson's disease. Mov. Dis., 5, 294-297.
21. Shoffner, J.M., Watts, R.L., Juncos, J.L., Torroni, A. and Wallace, D.C. (1991): Mitochondrial oxidative phosphorylation defects in Parkinson's disease. Ann. Neurol., 30, 332-339.
22. Sugiyama, Y. and Fujita, T. (1985): Stimulation of the respiratory and phosphorylating activities in rat brain mitochondria by idebenone (CV-2619), a new agent improving cerebral metabolism. FEBS Lett., 184, 48-51.
23. Sugiyama, Y., Fujita, T., Matsumoto, M., Okamoto, K. and Imada, I. (1985): Effect of idebenone (CV-2619) and its metabolites on respiratory activity and lipid peroxidation in brain mitochondria from rats and dogs. J. Pharmacobio-Dyn., 8, 1006-1017.
24. Suno, M. and Nagaoka, A. (1989): Inhibition of lipid peroxidation by idebenone in brain mitochondria in the presence of succinate. Arch. Gerontol. Geriatr., 8, 291-298.
25. Tritschler, H.J. and Medori, R. (1993): Mitochondrial DNA alterations as a source of human disorders. Neurology, 43, 280-288.
26. Yamazaki, M., Igarashi, H., Hamamoto, M., Miyazaki, T. and Nonaka, I. (1991): A case of mitochondrial encephalomyopathy with schizophrenic psychosis, dementia and neuroleptic malignant syndrome. Rinsho Shinkeigaku, 31, 1219-1223.
27. Yamazaki, N., Nomura, M., Nagaoka, A. and Nagawa, Y. (1989): Idebenone improves learning and memory impairment induced by cholinergic or serotonergic dysfunction in rats. Arch. Gerontol. Geriatr., 8, 225-239.
28. Zs-Nagy, I. (1990): Chemistry, toxicology, pharmacology and pharmacokinetics of idebenone: a review. Arch. Gerontol. Geriatr., 11, 177-186.
29. Zs-Nagy, I. and Floyd, R.A. (1990): ESR spin trapping studies on the OH free radical reactions of idebenone. Arch. Gerontol. Geriatr., 11, 215-232.